(Q41060472)

26 September 2017

1 reference

title

Drug therapy of non-insulin-dependent diabetes mellitus in the elderly (English)

1 reference

26 September 2017

A D Mooradian

1

1 reference

26 September 2017

1 June 1996

1 reference

26 September 2017

1 reference

26 September 2017

51

1 reference

26 September 2017

6

1 reference

26 September 2017

931-941

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199651060-00002

26 September 2017

0 references

cites work

Safety Profile of Acarbose, an α-Glucosidase Inhibitor

1 reference

12 December 2020

Metformin improves peripheral vascular flow in nonhyperlipidemic patients with arterial disease.

1 reference

12 December 2020

Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.

1 reference

12 December 2020

Selected vitamins and minerals in diabetes

1 reference

12 December 2020

1 reference

12 December 2020

The effect of sulphonylurea on the in vivo tissue uptake of glucose in normal rats.

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Severe Hypoglycaemia During Treatment with Glipizide

1 reference

12 December 2020

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

12 December 2020

United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years

1 reference

12 December 2020

Epidemiology of adverse drug reactions to phenformin and metformin

1 reference

12 December 2020

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

12 December 2020

Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Combination insulin-sulfonylurea therapy

1 reference

12 December 2020

Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents

1 reference

12 December 2020

Diabetes mellitus in elderly patients. Is it different?

1 reference

12 December 2020

Sulphonylureas and hypoglycaemia

1 reference

12 December 2020

Prevalence of diabetic complications in relation to risk factors

1 reference

12 December 2020

Sulfonylureas in NIDDM.

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

Malabsorption of Vitamin B12 in Diabetic Patients Treated with Phenformin: A Comparison with Metformin

1 reference

12 December 2020

Hemobiological activity of gliclazide in diabetes mellitus

1 reference

12 December 2020

1 reference

12 December 2020

Nutritional status and dietary management of elderly diabetic patients

1 reference

12 December 2020

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

12 December 2020

1 reference

12 December 2020

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

1 reference

12 December 2020

Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.

1 reference

12 December 2020

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

1 reference

12 December 2020

The treatment of NIDDM in the decade of the 90s

1 reference

12 December 2020

1 reference

12 December 2020

Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production

1 reference

12 December 2020

Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects.

1 reference

12 December 2020

Biological and functional definition of the older patient: the role of biomarkers of aging

1 reference

12 December 2020

Are oral hypoglycemic agents likely to benefit NIDDM patients? Affirmative

1 reference

12 December 2020

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

12 December 2020

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

12 December 2020

Scope and specificity of acarbose in slowing carbohydrate absorption in man

1 reference

12 December 2020

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

12 December 2020

Metformin and the sulphonylureas: the comparative risk

1 reference

12 December 2020

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

12 December 2020

Diarrhea and Metformin in a Diabetic Clinic

1 reference

12 December 2020

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

1 reference

12 December 2020

Diabetes mellitus in elderly nursing home patients. A survey of clinical characteristics and management

1 reference

12 December 2020

10.2165/00003495-199651060-00002

Identifiers

DOI

1 reference

PubMed ID

8736615

Dimensions Publication ID

26 September 2017

0 references

1 reference

PubMed ID

8736615